Pre IPO we were looking at it and could see: No exits to point to and a horrendously high salary list.
It was never going to succeed
- Forums
- ASX - By Stock
- PVL
- Ann: Appendix 4E and Full Year Statutory Accounts
Ann: Appendix 4E and Full Year Statutory Accounts, page-3
Featured News
Add PVL (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
-0.008(9.52%) |
Mkt cap ! $9.480M |
Open | High | Low | Value | Volume |
7.6¢ | 7.6¢ | 7.6¢ | $5.531K | 72.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 58139 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 0.078 |
1 | 16500 | 0.075 |
1 | 175000 | 0.074 |
2 | 100000 | 0.070 |
1 | 50000 | 0.064 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 58139 | 1 |
0.088 | 100000 | 1 |
0.090 | 350 | 1 |
0.095 | 300000 | 1 |
0.100 | 299546 | 3 |
Last trade - 14.37pm 12/11/2024 (20 minute delay) ? |
Featured News
PVL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online